rxstat › Shortages › Fingolimod

Fingolimod shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Fingolimod products are in shortage in Canada (3 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
3 / 8
In shortage since
Mar 4, 2022
Reports on file
15
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
MYLAN-FINGOLIMOD
0.5MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02469715 · since Jul 7, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-FINGOLIMOD
0.5MG · CAPSULE · APOTEX INC
DIN 02469936 · since May 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-FINGOLIMOD
0.5MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02475669 · since Mar 4, 2022, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Resolved
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Resolved
JAMP FINGOLIMOD
0.5MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02487772 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Resolved
MAR-FINGOLIMOD
0.5MG · CAPSULE · MARCAN PHARMACEUTICALS INC
DIN 02474743 · ended Jul 6, 2022 · Other (Please describe in comments)
Resolved
GILENYA
0.25MG · CAPSULE · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02482533 · ended Jun 6, 2023 · Delay in shipping of the drug.
Resolved
MYLAN-FINGOLIMOD
0.5MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02469715 · ended May 1, 2023 · Shortage of an active ingredient.

Showing 12 of 15 reports. All reports are on file with Health Canada.

What's happening

Fingolimod is currently affected by 3 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, APOTEX INC, ACCORD HEALTHCARE INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

When will Fingolimod be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Fingolimod in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Widespread shortageApremilast2 of 3 reported products affectedPartial shortageAdalimumab1 of 7 reported products affectedPartial shortageApremilast Apremilast Apremilast1 of 1 reported products affected · est. return Aug 28, 2026Partial shortageBasiliximab1 of 1 reported products affectedPartial shortageCyclosporine1 of 8 reported products affected · est. return Jul 30, 2027Partial shortageLeflunomide3 of 15 reported products affected · est. return Jul 24, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.